N Selvamurugan Selected Research

Activating Transcription Factor 3

12/2021	TGF-β1-stimulation of NFATC2 and ATF3 proteins and their interaction for matrix metalloproteinase 13 expression in human breast cancer cells.
12/2020	A computational study of non-coding RNAs on the regulation of activating transcription factor 3 in human breast cancer cells.
8/2019	Stimulation of ATF3 interaction with Smad4 via TGF-β1 for matrix metalloproteinase 13 gene activation in human breast cancer cells.
11/2018	miR-590-3p inhibits proliferation and promotes apoptosis by targeting activating transcription factor 3 in human breast cancer cells.
1/2017	Transforming growth factor-β1 regulation of ATF-3, c-Jun and JunB proteins for activation of matrix metalloproteinase-13 gene in human breast cancer cells.
3/2015	Runx2, a target gene for activating transcription factor-3 in human breast cancer cells.
1/2015	A feedback expression of microRNA-590 and activating transcription factor-3 in human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Selvamurugan Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2000
8	Neoplasm Metastasis (Metastasis) 10/2021 - 04/2000
6	Neoplasms (Cancer) 10/2021 - 04/2000
2	Wounds and Injuries (Trauma) 01/2022 - 02/2018
2	Pathologic Processes 01/2015 - 04/2000
1	Bone Diseases (Bone Disease) 02/2021
1	Infections 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hypoxia (Hypoxemia) 12/2018
1	Osteoporosis 02/2018
1	Polyps 02/2018
1	Osteomyelitis 02/2018
1	Bone Resorption 10/2015
1	Osteosarcoma (Osteogenic Sarcoma) 02/2000

Drug/Important Bio-Agent (IBA)

7	Activating Transcription Factor 3IBA 12/2021 - 01/2015
6	Matrix Metalloproteinase 13IBA 12/2021 - 02/2000
6	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2000
4	Transcription Factors (Transcription Factor)IBA 10/2021 - 03/2015
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2021 - 01/2017
2	Circular RNAIBA 08/2021 - 12/2020
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 04/2000
1	ChitosanIBA 01/2022
1	pullulanIBA 01/2022
1	Cytidine Monophosphate (CMP)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Histones (Histone)IBA 02/2021
1	calcium silicate (Wollastonite)IBA 01/2021
1	ZincIBA 01/2021
1	PhytochemicalsIBA 01/2020
1	CytokinesIBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	IronIBA 02/2018
1	Biocompatible Materials (Biomaterials)IBA 02/2018
1	PolymersIBA 02/2018
1	PolyphosphatesIBA 02/2018
1	EnzymesIBA 10/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2015
1	Small Untranslated RNAIBA 01/2015
1	Parathyroid Hormone (Parathormone)IBA 02/2000
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 02/2000

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2017
1	Drug Therapy (Chemotherapy) 08/2021